BioLife Solutions Inc
NASDAQ:BLFS
BioLife Solutions Inc
NASDAQ:BLFS
Price:
18.36
USD
1.16%
Market Closed
Market Cap:
$884m
Relative Value
The Relative Value of one
BLFS
stock under the Base Case scenario is
8.99
USD.
Compared to the current market price of 18.36 USD,
BioLife Solutions Inc
is
Overvalued by 51%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BLFS
Relative Value
Base Case
8.99
USD
Overvaluation 51%
Multiples Across Competitors
BLFS Competitors Multiples
BioLife Solutions Inc Competitors
BioLife Solutions Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
BioLife Solutions Inc
NASDAQ:BLFS
|
884.9m USD | 9.7 | -203.3 | 234.1 | -781.1 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.4T JPY | 10.2 | 37.5 | 27.1 | 32.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
54.5B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.8B CHF | 3.7 | 39 | 15 | 29.1 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
101.3B DKK | 3.7 | 25.6 | 13.4 | 16 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
11.7B USD | 2.9 | 28.6 | 12.3 | 16.9 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP | 2.6 | 36 | 14.3 | 24.4 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
41.8B CNY | 9.2 | 25.3 | 22.8 | 22.8 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.7B USD | 1.1 | -15.9 | 17 | 55.2 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.1B USD | 3.3 | 21.9 | 14 | 17.2 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
819.6B JPY | 6.3 | 46.3 | 21.8 | 29.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
